Trial
NCT03729297
Cabozantinib in Advanced Salivary Gland Cancer Patients
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Radboud University Medical Center
Collaborators
Ipsen
Condition
Salivary Gland Cancer
Intervention
Cabozantinib
Why stopped
safety issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-12